Publications (607) JACQUES JM VAN DONGEN publications

2024

  1. A transcriptomic based deconvolution framework for assessing differentiation stages and drug responses of AML

    npj Precision Oncology, Vol. 8, Núm. 1

  2. Analysis of measurable residual disease by IG/TR gene rearrangements: quality assurance and updated EuroMRD guidelines

    Leukemia, Vol. 38, Núm. 6, pp. 1315-1322

  3. Disruption of memory B-cell trafficking by belimumab in patients with systemic lupus erythematosus

    Rheumatology (United Kingdom), Vol. 63, Núm. 9, pp. 2387-2398

  4. Longitudinal soluble marker profiles reveal strong association between cytokine storms resulting from macrophage activation and disease severity in COVID-19 disease

    Scientific Reports, Vol. 14, Núm. 1

  5. Minimal residual disease assessment in B-cell precursor acute lymphoblastic leukemia by semi-automated identification of normal hematopoietic cells: A EuroFlow study

    Cytometry Part B - Clinical Cytometry, Vol. 106, Núm. 4, pp. 252-263

  6. The gray area of RQ-PCR-based measurable residual disease: subdividing the “positive, below quantitative range” category

    Leukemia

2023

  1. Age-Dependent Normalization Functions for T Lymphocytes in Healthy Individuals

    ImmunoHorizons, Vol. 210, Núm. 12, pp. 1882-1888

  2. Autoantibody subclass predominance is not driven by aberrant class switching or impaired B cell development

    Clinical Immunology, Vol. 257

  3. Automated EuroFlow approach for standardized in-depth dissection of human circulating B-cells and plasma cells

    Frontiers in Immunology, Vol. 14

  4. Baseline immunophenotypic profile of bone marrow leukemia cells in acute myeloid leukemia with nucleophosmin-1 gene mutation: a EuroFlow study

    Blood Cancer Journal

  5. Carriers of the p.P522R variant in PLCγ2 have a slightly more responsive immune system

    Molecular Neurodegeneration, Vol. 18, Núm. 1

  6. Daily disease severity in patients with COVID-19 admitted to the hospital: The SCODA (severity of coronavirus disease assessment) score

    PLoS ONE, Vol. 18, Núm. 9 September

  7. Distinct early cellular kinetics in participants protected against colonization upon Bordetella pertussis challenge

    The Journal of clinical investigation, Vol. 133, Núm. 5

  8. Editorial: Multi-omics data integration: key to thoroughly understanding the immune system

    Frontiers in Cell and Developmental Biology

  9. Experience with IVDR Implementation in Three Diagnostic Laboratories: Messages to EU Health Institutions, Diagnostic Healthcare Payers, and Authorities

    HemaSphere

  10. Host biomarker-based quantitative rapid tests for detection and treatment monitoring of tuberculosis and COVID-19

    iScience, Vol. 26, Núm. 1

  11. Immune cell kinetics and antibody response in COVID-19 patients with low-count monoclonal B-cell lymphocytosis

    American Journal of Hematology, Vol. 98, Núm. 12, pp. 1909-1922

  12. In-depth blood immune profiling of Good syndrome patients

    Frontiers in Immunology, Vol. 14

  13. Patient specific real-time PCR in precision medicine – Validation of IG/TR based MRD assessment in lymphoid leukemia

    Frontiers in Oncology, Vol. 12

  14. Performance of spectral flow cytometry and mass cytometry for the study of innate myeloid cell populations

    Frontiers in Immunology, Vol. 14